Related Experiment Videos
[Home management of bronchopulmonary dysplasia]
1Service Universitaire de Néonatologie, CHR de la Citadelle, Liège, Belgique.
Insights
Bronchopulmonary dysplasia is a common respiratory issue in infants surviving neonatal intensive care. Management strategies vary based on disease severity to ensure optimal growth and well-being.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Respiratory Medicine
Context:
- Bronchopulmonary dysplasia (BPD) is a significant clinical challenge in neonatal intensive care survivors.
- BPD is the leading cause of chronic respiratory insufficiency in infants.
- The condition's severity ranges from asymptomatic to requiring long-term ventilation and oxygen therapy.
Purpose:
- To discuss the management of bronchopulmonary dysplasia based on disease severity.
- To outline current treatment modalities including medications, oxygen therapy, and follow-up protocols.
- To address the goals of care, focusing on growth, neurodevelopment, and patient well-being.
Summary:
- Bronchopulmonary dysplasia (BPD) management requires a severity-based approach.
- Treatment includes aerosol therapy, diuretics, steroids, and tailored oxygen therapy.
- Follow-up and expected evolution are critical components of BPD care.
Impact:
- Provides a framework for managing infants with bronchopulmonary dysplasia.
- Highlights the variability in BPD severity and its impact on patient outcomes.
- Emphasizes the importance of comprehensive care for growth, neurodevelopment, and quality of life.
Abstract:
Bronchopulmonary dysplasia remains a significant clinical problem associated with the success on survival of neonatal intensive care and has become the common est cause of respiratory insufficiency in infants. The severity of the disease is highly variable from asymptomatic chronic lung disease to patients needing home care with continuous oxygenotherapy and artificial ventilation. Management must try to insure not only appropriate growth and neurodevelopment but also satisfactory well being of the patients. Current medications (aerosoltherapy, diuretics, steroids), rules for oxygenotherapy, follow-up and expected evolution are discussed according to the severity of the disease.